FDA Publishes Draft Guidance for Electrocardiograph Electrodes

Summary

The Food and Drug Administration (FDA) has released a draft guidance document outlining how electrocardiograph electrode devices can meet special controls for Class II medical devices, and proposes a rule to exempt these devices from premarket notification requirements if they follow the guidance's recommendations.